Page last updated: 2024-09-04

moxifloxacin and Hyperglycemia, Postprandial

moxifloxacin has been researched along with Hyperglycemia, Postprandial in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (50.00)29.6817
2010's1 (16.67)24.3611
2020's2 (33.33)2.80

Authors

AuthorsStudies
Camm, AJ; Cole, ST; Graff, C; Kanters, JK; Pimenta, D; Taubel, J1
Uz, B1
Chang, CH; Chou, HW; Lai, MS; Lee, JJ; Shau, WY; Wang, JL1
Choudhri, S; Gavin, JR; Gross, R; Himmel, H; Kubin, R; Kubitza, D; Meyer, JM1
Cornish, W; Knowles, S; Phillips, EJ; Rachlis, A; Simor, AE; Tailor, SA1
Catero, M1

Reviews

1 review(s) available for moxifloxacin and Hyperglycemia, Postprandial

ArticleYear
Dysglycemia and fluoroquinolones: are you putting patients at risk?
    The Journal of family practice, 2007, Volume: 56, Issue:2

    Topics: Adolescent; Adult; Aza Compounds; Bacterial Infections; Blood Glucose; Ciprofloxacin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Approval; Evidence-Based Medicine; Family Practice; Female; Fluoroquinolones; Gatifloxacin; Humans; Hyperglycemia; Hypoglycemia; Incidence; Male; Middle Aged; Moxifloxacin; Ofloxacin; Quinolines; Randomized Controlled Trials as Topic; Risk Assessment; United States; United States Food and Drug Administration

2007

Trials

1 trial(s) available for moxifloxacin and Hyperglycemia, Postprandial

ArticleYear
Effect of hyperglycaemia in combination with moxifloxacin on cardiac repolarization in male and female patients with type I diabetes.
    Clinical research in cardiology : official journal of the German Cardiac Society, 2022, Volume: 111, Issue:10

    Topics: Blood Glucose; Cross-Over Studies; Death, Sudden, Cardiac; Diabetes Mellitus, Type 1; Double-Blind Method; Female; Heart Rate; Humans; Hyperglycemia; Insulins; Long QT Syndrome; Male; Moxifloxacin

2022

Other Studies

4 other study(ies) available for moxifloxacin and Hyperglycemia, Postprandial

ArticleYear
Moxifloxacin-Induced Visual Hallucinations, Alterations in Mood and Behavior, and Hyperglycemia.
    Journal of pharmacy practice, 2020, Volume: 33, Issue:3

    Topics: Aged; Female; Hallucinations; Humans; Hyperglycemia; Moxifloxacin

2020
Risk of severe dysglycemia among diabetic patients receiving levofloxacin, ciprofloxacin, or moxifloxacin in Taiwan.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2013, Volume: 57, Issue:7

    Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Aza Compounds; Ciprofloxacin; Cohort Studies; Diabetes Complications; Female; Fluoroquinolones; Humans; Hyperglycemia; Hypoglycemia; Levofloxacin; Male; Middle Aged; Moxifloxacin; Odds Ratio; Propensity Score; Quinolines; Taiwan

2013
Moxifloxacin and glucose homeostasis: a pooled-analysis of the evidence from clinical and postmarketing studies.
    Drug safety, 2004, Volume: 27, Issue:9

    Topics: Animals; Anti-Bacterial Agents; Aza Compounds; Blood Glucose; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Diabetes Mellitus; Fluoroquinolones; Glucose; Homeostasis; Humans; Hyperglycemia; Hypoglycemia; Male; Moxifloxacin; Product Surveillance, Postmarketing; Quinolines; Rats

2004
Glucose homeostasis abnormalities and gatifloxacin.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2006, Mar-15, Volume: 42, Issue:6

    Topics: Aza Compounds; Fluoroquinolones; Gatifloxacin; Glucose; Homeostasis; Humans; Hyperglycemia; Hypoglycemia; Moxifloxacin; Ofloxacin; Quinolines

2006